Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.34 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.34 |
| ▸ | WNT3A | P56704 | 1/20 | 0.34 |
| ▸ | MALT1 | Q9UDY8 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL782140 | 0.85 | DHODH (0.42) | KMT2ANTRK1MALT1 | |
| SCHEMBL2138320 | 0.82 | MEN1 (0.35) | RIPK1KMT2AMEN1TP53 | |
| SCHEMBL10140197 | 0.82 | DHODH (0.41) | L3MBTL1KMT2ANTRK1MALT1 | |
| SCHEMBL29369827 | 0.82 | SCN9A (0.34) | KMT2AMEN1MAPTNPSR1POLB | |
| SCHEMBL12528155 | 0.82 | KMT2A (0.44) | L3MBTL1KMT2AMEN1TP53NTRK1 | |
| SCHEMBL12175343 | 0.82 | SCN9A (0.34) | KMT2AMEN1MAPTNPSR1POLB | |
| SCHEMBL15187947 | 0.79 | LMNA (0.32) | L3MBTL1KMT2AMEN1MAPTNPSR1 | |
| SCHEMBL15187946 | 0.79 | SCN9A (0.32) | L3MBTL1KMT2AMEN1 | |
| SCHEMBL4664524 | 0.79 | TSHR (0.38) | RIPK1KMT2ACNR2TP53ALDH1A1 | |
| SCHEMBL12528992 | 0.79 | TP53 (0.35) | RIPK1KMT2ACNR2MEN1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090076092-A1 | METHOD FOR DISRUPTING REPRODUCTIVE PERFORMANCE OF ARTHROPODS | ANNAN ISSAC BILLY | 2009-03-19 | — | — | US | claimed |
| US-20180168158-A1 | ANTHRANILAMIDE SEED TREATMENT COMPOSITIONS AND METHODS OF USE | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2018-06-21 | — | — | US | disclosed |
| US-9826737-B2 | Solid formulations of carboxamide arthropodicides | E I DU PONT DE NEMOURS AND COMPANY (US) | 2017-11-28 | — | — | US | disclosed |
| US-20170215419-A1 | ANTHRANILAMIDE SEED TREATMENT COMPOSITIONS AND METHODS OF USE | E I DUPONT DE NEMOURS AND COMPANY | 2017-08-03 | — | — | US | disclosed |
| US-9332756-B2 | Liquid formulations of carboxamide arthropodicides | E I DU PONT DE NEMOURS AND COMPANY (US) | 2016-05-10 | — | — | US | disclosed |
| WO-2016019013-A1 | ANTHRANILAMIDE SEED TREATMENT COMPOSITIONS AND METHODS OF USE | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2016-02-04 | — | — | WO | disclosed |
| US-8709513-B2 | Liquid formulations of carboxamide arthropodicides | E I DU PONT DE NEMOURS AND COMPANY (DE) | 2014-04-29 | — | — | US | disclosed |
| US-20140005048-A1 | SOLID FORMULATIONS OF CARBOXAMIDE ARTHROPODICIDES | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-01-02 | — | — | US | disclosed |
| EP-2094092-B1 | LIQUID FORMULATIONS OF CARBOXAMIDE ARTHROPODICIDES | DU PONT (US) | 2012-10-31 | — | — | EP | disclosed |
| US-20110059846-A1 | SOLID FORMULATIONS OF CARBOXAMIDE ARTHROPODICIDES | E. I. DU PONT DE NEMOURS AND COMPANY | 2011-03-10 | — | — | US | disclosed |
| US-20100137374-A1 | SOLID FORMULATIONS OF CARBOXAMIDE ARTHROPODICIDES | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2010-06-03 | — | — | US | disclosed |
| US-20100055084-A1 | LIQUID FORMULATIONS OF CARBOXAMIDE ARTHROPODICIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-03-04 | — | — | US | disclosed |
| EP-1968382-B1 | LIQUID FORMULATIONS OF CARBOXAMIDE ARTHROPODICIDES | DU PONT (US) | 2009-09-16 | — | — | EP | disclosed |
| US-20090076092-A1 | METHOD FOR DISRUPTING REPRODUCTIVE PERFORMANCE OF ARTHROPODS | ANNAN ISSAC BILLY | 2009-03-19 | — | — | US | disclosed |
| EP-2001300-A2 | METHOD FOR DISRUPTING REPRODUCTIVE PERFORMANCE OF ARTHROPODS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-12-17 | — | — | EP | disclosed |
| US-20080305093-A1 | Liquid Formulations of Carboxamide Arthropodicides | FMC IP TECHNOLOGY GMBH (CH) | 2008-12-11 | — | — | US | disclosed |
| WO-2008021152-A2 | AGRONOMIC METHOD | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-02-21 | — | — | WO | disclosed |
| WO-2007126636-A2 | METHOD FOR DISRUPTING REPRODUCTIVE PERFORMANCE OF ARTHROPODS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-11-08 | — | — | WO | disclosed |
| US-20070184018-A1 | Anthranilamide insecticides | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137374-A1 | SOLID FORMULATIONS OF CARBOXAMIDE ARTHROPODICIDES | FAAH, FAAH2, CNR2 | L3MBTL1 3972/4885RIPK1 3364/4885KMT2A 1871/4885 |
| US-20090076092-A1 | METHOD FOR DISRUPTING REPRODUCTIVE PERFORMANCE OF ARTHROPODS | NASP, CPS1, CYP11A1 | L3MBTL1 494/4885RIPK1 2069/4885KMT2A 1122/4885 |
| US-20080305093-A1 | Liquid Formulations of Carboxamide Arthropodicides | FAAH, C9, FAAH2 | L3MBTL1 1070/4885RIPK1 968/4885KMT2A 1698/4885 |
| US-20180168158-A1 | ANTHRANILAMIDE SEED TREATMENT COMPOSITIONS AND METHODS OF USE | AADAC, ABL2, API5 | L3MBTL1 3359/4885RIPK1 4048/4885KMT2A 1517/4885 |
| US-20070184018-A1 | Anthranilamide insecticides | F12, CBR3, F3 | L3MBTL1 468/4885RIPK1 3800/4885KMT2A 1133/4885 |
| US-20100055084-A1 | LIQUID FORMULATIONS OF CARBOXAMIDE ARTHROPODICIDES | FAAH, CHIA, FAAH2 | L3MBTL1 1118/4885RIPK1 1414/4885KMT2A 1243/4885 |
| US-20140005048-A1 | SOLID FORMULATIONS OF CARBOXAMIDE ARTHROPODICIDES | FAAH, CNR2, FAAH2 | L3MBTL1 4414/4885RIPK1 3873/4885KMT2A 2958/4885 |
| US-20110059846-A1 | SOLID FORMULATIONS OF CARBOXAMIDE ARTHROPODICIDES | FAAH, CNR2, FAAH2 | L3MBTL1 4414/4885RIPK1 3873/4885KMT2A 2958/4885 |
| US-20170215419-A1 | ANTHRANILAMIDE SEED TREATMENT COMPOSITIONS AND METHODS OF USE | AADAC, ABL2, API5 | L3MBTL1 3359/4885RIPK1 4048/4885KMT2A 1517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.